Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution. They negotiate rebates, design formularies, adjudicate claims, and steer patient adherence. Modern artificial intelligence (AI) is designed to compress each…
Our 24/7 Wall St. price target for CVS Health (NYSE:CVS | CVS Price Prediction) is $125.45, pointing to meaningful upside from where shares trade today. The stock closed at $86.86 on May…
Vandita Jadeja William Blair launched coverage of Cardinal Health (NYSE:CAH | CAH Price Prediction) with an Outperform rating today, framing the pharma distributor as a durable franchise with specialty-led upside. The firm simultaneously initiated…
Amazon (NASDAQ: AMZN | AMZN Price Prediction) just made a quiet move that could reshape how Americans access weight-loss drugs. On April 9, 2026, it announced that its pharmacy unit will stock…
The Centers for Medicare & Medicaid Services (CMS) finalized the 2027 Medicare Advantage payment rate at a +2.48% net average increase, well above the +0.09% proposed in January and above the roughly…
CVS Health (NYSE: CVS | CVS Price Prediction) and Cigna Group (NYSE: CI) are both major players in American healthcare. For retirement investors choosing between them, the key question is: do you…
Oscar Health (NYSE:OSCR | OSCR Price Prediction) CEO Mark Bertolini has been making the same promise for four consecutive quarters: 2026 is the year the company turns profitable. Now, with the Q4…
Graco just paid investors $0.295 per share on February 4, 2026, marking the company’s 27th consecutive year of quarterly dividend payments. This industrial equipment manufacturer has quietly built one of the more…
At a Glance Revenue: $105.69 billion (beat consensus of $104.63 billion) Adjusted EPS: $1.09 (beat consensus of $1.00) GAAP EPS: $2.30 vs. $1.30 prior year (includes $1.9 billion tax benefit from subsidiary…
Trey Thoelcke CVS Health (NYSE: CVS | CVS Price Prediction) reported third-quarter results this morning that beat adjusted earnings expectations but delivered a mixed message on operations and cash flow. Adjusted EPS came in…
Joel South Healthcare investing has felt like walking through quicksand this year. One moment, the sector looks ready to spring forward on breakthrough drugs and aging demographics, the next, it is yanked back by…
Jim Cramer, the charismatic host of CNBC’s Mad Money, has become a household name for investors seeking bold, actionable insights. Known for his high-energy delivery and colorful metaphors, Cramer blends deep market…
A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO | NVO Price Prediction) has been a trailblazer in the GLP-1 drug market, revolutionizing diabetes and obesity treatment with its blockbuster…
Live Updates Thursday Wrap-up4:20pm ETThe Vanguard S&P 500 ETF closed Thursday almost flat at 592.77, down just 0.01%. Ask Sherwin-Williams... Why Its Stock is Going Down1:32pm ETBofA Securities analyst Steve Byrne removed…
Three familiar dividend stocks are ideal choices for growth and income investors seeking reliable passive income with growth potential.
